Drug intelligence / Profile preview

carisoprodol

Development stage
Approved
Lead developer
Wallace Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

Carisoprodol is an oral, centrally acting skeletal muscle relaxant used to relieve discomfort associated with acute, painful musculoskeletal conditions. It is typically prescribed alongside rest and physical therapy for short-term use (up to two or three weeks). Carisoprodol acts on the central nervous system rather than directly on skeletal muscle. Its precise mechanism of action is not fully established but involves modulation of interneuronal activity in the spinal cord and brainstem reticular formation. A significant portion of carisoprodol is metabolized into meprobamate, a compound with anxiolytic and sedative properties that acts as a GABAA receptor modulator. This metabolite contributes to both its therapeutic effects and its potential for abuse and dependence[1][2][3][4][5][8].

Brand names
SomaVanadom
Other names
carisoprodol
02

Targets

GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on carisoprodol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carisoprodol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call